Basel Medical Group Ltd
BMGL- Exchange
- Nasdaq
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- SEC CIK
- 0002004489
No open-market purchases or sales by Basel Medical Group Ltd insiders were filed in the last 90 days; 2 institutions reported holding it in 13F filings for Q2 2026, worth $3.44K in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Basel Medical Group Ltd as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 4
- −6 vs. Q4 2025
- Shares held
- 53.9K
- −89.4K (−62.4%) vs. Q4 2025
- Total value
- $32.2K
- −$38.0K (−54.1%) vs. Q4 2025
- New holders
- 1
- 1 more added
- Sold out
- 7
- 1 more reduced
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BMGL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 2 | $3.44K |
| Q1 2026 | 4 | $32.2K |
| Q4 2025 | 10 | $70.2K |
| Q3 2025 | 10 | $524.6K |
| Q2 2025 | 6 | $221.2K |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Basel Medical Group Ltd; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| XTX Topco Ltd | 25,756 | $15.7K | 0.00% | −4,674−15.4% | Reduced |
| T3 Companies, LLC | 15,000 | $8.85K | 0.01% | +15,000 | New |
| UBS Group AG | 13,056 | $7.70K | 0.00% | +4,967+61.4% | Added |
| Coston, McIsaac & Partners | 50 | $0 | 0.00% | 00.0% | Unchanged |
| Ground Swell Capital, LLC | 0 | $0 | 0.00% | −33,705−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −24,672−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −16,288−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −15,290−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −14,498−100.0% | Sold out |
| Bell Investment Advisors, Inc | 0 | $0 | 0.00% | −248−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −1−100.0% | Sold out |